MX2007003911A - Derivados y usos de benzoxazina y quinoxalina. - Google Patents
Derivados y usos de benzoxazina y quinoxalina.Info
- Publication number
- MX2007003911A MX2007003911A MX2007003911A MX2007003911A MX2007003911A MX 2007003911 A MX2007003911 A MX 2007003911A MX 2007003911 A MX2007003911 A MX 2007003911A MX 2007003911 A MX2007003911 A MX 2007003911A MX 2007003911 A MX2007003911 A MX 2007003911A
- Authority
- MX
- Mexico
- Prior art keywords
- benzoxazine
- quinoxaline derivatives
- preparation
- r4are
- medicament
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describen compuestos de la formula I: o una sal farmaceuticamente aceptable de los mismos, donde k, m, n, p, q, X, Y, Z, Ar, R1, R2, R3 y R4 y son como se ha definido aqui, asi como metodos para la preparacion de los mismos, composiciones farmaceuticas que los contengan y el uso de los mismos para la preparacion de un medicamento.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61470504P | 2004-09-30 | 2004-09-30 | |
US63060804P | 2004-11-24 | 2004-11-24 | |
PCT/EP2005/010238 WO2006037481A1 (en) | 2004-09-30 | 2005-09-22 | Benzoxazine and quinoxaline derivatives and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007003911A true MX2007003911A (es) | 2007-05-21 |
Family
ID=35385358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007003911A MX2007003911A (es) | 2004-09-30 | 2005-09-22 | Derivados y usos de benzoxazina y quinoxalina. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1797051B1 (es) |
JP (1) | JP2008514662A (es) |
KR (1) | KR100875041B1 (es) |
AR (1) | AR051115A1 (es) |
AT (1) | ATE477248T1 (es) |
AU (1) | AU2005291541B2 (es) |
BR (1) | BRPI0516754A (es) |
CA (1) | CA2581921A1 (es) |
DE (1) | DE602005022896D1 (es) |
IL (1) | IL182304A0 (es) |
MX (1) | MX2007003911A (es) |
MY (1) | MY139409A (es) |
NO (1) | NO20071616L (es) |
NZ (1) | NZ553848A (es) |
RU (1) | RU2382036C2 (es) |
TW (1) | TW200626567A (es) |
WO (1) | WO2006037481A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101031338B (zh) * | 2004-09-30 | 2013-01-02 | 弗·哈夫曼-拉罗切有限公司 | 治疗认知障碍的组合物和方法 |
CL2007003044A1 (es) * | 2006-10-24 | 2008-07-04 | Wyeth Corp | Compuestos derivados de benzoxazina; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y abuso o dependencia de sustancias entre otros. |
US8044047B2 (en) * | 2008-09-08 | 2011-10-25 | Hoffman-La Roche Inc. | 5-substituted benzoxazines |
SG11201610407QA (en) * | 2014-07-08 | 2017-01-27 | Sunshine Lake Pharma Co Ltd | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW224941B (es) * | 1989-11-08 | 1994-06-11 | Yamanouchi Pharma Co Ltd | |
BR9916326A (pt) * | 1998-12-17 | 2001-10-02 | American Home Prod | Derivados de 2,3,4,4a-tetrahidro-1h-pirazino(1,2-a)quinoxalin-5-(6h) ona sendo agonistas de 5ht2c |
MXPA04003087A (es) * | 2001-10-04 | 2004-09-06 | Wyeth Corp | Derivados de cromano como ligados de 5-hidroxitriptamina-6. |
MXPA04011254A (es) * | 2002-05-13 | 2005-01-25 | Hoffmann La Roche | Derivados de benzoxazina como moduladores de 5-hidroxitriptamina 6 (5-ht6) y usos de los mismos. |
CN101031338B (zh) * | 2004-09-30 | 2013-01-02 | 弗·哈夫曼-拉罗切有限公司 | 治疗认知障碍的组合物和方法 |
-
2005
- 2005-09-22 WO PCT/EP2005/010238 patent/WO2006037481A1/en active Application Filing
- 2005-09-22 DE DE602005022896T patent/DE602005022896D1/de active Active
- 2005-09-22 KR KR1020077007227A patent/KR100875041B1/ko not_active IP Right Cessation
- 2005-09-22 JP JP2007533918A patent/JP2008514662A/ja active Pending
- 2005-09-22 AT AT05796666T patent/ATE477248T1/de active
- 2005-09-22 BR BRPI0516754-0A patent/BRPI0516754A/pt not_active IP Right Cessation
- 2005-09-22 EP EP05796666A patent/EP1797051B1/en active Active
- 2005-09-22 NZ NZ553848A patent/NZ553848A/en not_active IP Right Cessation
- 2005-09-22 AU AU2005291541A patent/AU2005291541B2/en not_active Expired - Fee Related
- 2005-09-22 MX MX2007003911A patent/MX2007003911A/es active IP Right Grant
- 2005-09-22 RU RU2007110479/04A patent/RU2382036C2/ru not_active IP Right Cessation
- 2005-09-22 CA CA002581921A patent/CA2581921A1/en not_active Abandoned
- 2005-09-27 AR ARP050104050A patent/AR051115A1/es unknown
- 2005-09-27 TW TW094133563A patent/TW200626567A/zh unknown
- 2005-09-28 MY MYPI20054561A patent/MY139409A/en unknown
-
2007
- 2007-03-27 NO NO20071616A patent/NO20071616L/no not_active Application Discontinuation
- 2007-03-29 IL IL182304A patent/IL182304A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
MY139409A (en) | 2009-09-30 |
KR100875041B1 (ko) | 2008-12-19 |
JP2008514662A (ja) | 2008-05-08 |
AR051115A1 (es) | 2006-12-20 |
AU2005291541B2 (en) | 2011-03-10 |
IL182304A0 (en) | 2007-07-24 |
RU2007110479A (ru) | 2008-11-10 |
EP1797051B1 (en) | 2010-08-11 |
ATE477248T1 (de) | 2010-08-15 |
NZ553848A (en) | 2010-01-29 |
WO2006037481A1 (en) | 2006-04-13 |
CA2581921A1 (en) | 2006-04-13 |
DE602005022896D1 (de) | 2010-09-23 |
RU2382036C2 (ru) | 2010-02-20 |
BRPI0516754A (pt) | 2008-09-16 |
KR20070047844A (ko) | 2007-05-07 |
TW200626567A (en) | 2006-08-01 |
AU2005291541A1 (en) | 2006-04-13 |
NO20071616L (no) | 2007-04-25 |
EP1797051A1 (en) | 2007-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200642689A (en) | Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient | |
TNSN08407A1 (en) | Organic compounds | |
TW200626598A (en) | Pyrrazolo-pyrimidine derivatives | |
UA94065C2 (en) | Dihydropseudoerythromycin derivatives | |
MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
TW200621762A (en) | Novel compounds | |
TW200639156A (en) | New compounds | |
MY140638A (en) | New heterocyclic compounds, which are active as inhibitors of beta-lactamases | |
UA84878C2 (ru) | Производные 2-пиридона как ингибиторы нейтрофилов эластазы, фармацевтическая композиция на их основе, способ их получения | |
TW200502230A (en) | Dual nk1/nk3 derivatives | |
UA84712C2 (en) | N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors | |
WO2005021544A3 (en) | N3-substituted imidazopyridine-derivatives as c-kit inhibitors | |
NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
GEP20104875B (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
RS99804A (en) | Novel compounds and their use | |
GEP20104964B (en) | 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof | |
TW200728298A (en) | Thiophene compounds and thrombopoietin receptor activators | |
TW200724539A (en) | Benzimidazole derivative and use thereof | |
MX2007007480A (es) | Derivados de cromano y su uso como ligandos del receptor 5-ht. | |
MY139612A (en) | Benzoxazine derivatives as 5-th6 modulators and uses thereof | |
MY186650A (en) | Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives | |
TW200728291A (en) | Amide derivatives | |
MXPA05005790A (es) | Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central. | |
MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
TW200738697A (en) | Benzimidazole derivatives as 5-HT6,5-HT24 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |